Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
Journal of Bone and Joint Surgery - British Volume, Vol 91-B, Issue 7, 865-869.
doi: 10.1302/0301-620X.91B7.22311  
Copyright © 2009 by British Editorial Society of Bone and Joint Surgery
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Shah, N. N.
Right arrow Articles by Clark, D. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, N. N.
Right arrow Articles by Clark, D. W.

Hydroxyapatite-ceramic-coated femoral components in young patients followed-up for 16 to 19 years

AN UPDATE OF A PREVIOUS REPORT

N. N. Shah, MS, MSc, MCh(Orth), FRCS(Trauma & Orth), Furlong Clinical Fellow1; A. J. Edge, FRCS, Consultant Orthopaedic Surgeon1; and D. W. Clark, FRCS, Consultant Orthopaedic Surgeon1

1 Worthing & Southlands Hospitals NHS Trust, Southlands Hospital, Upper Shoreham Road, Shoreham-by-Sea, West Sussex BN43 6TQ, UK.

Correspondence should be sent to Mr N. N. Shah; e-mail: nns5511{at}aol.com

In 2004 we described the ten-year prospective results of 38 total hip replacements using the Furlong hydroxyapatite-ceramic-coated femoral component in 35 patients < 50 years old. We have now reviewed the surviving 35 arthroplasties in 33 patients at a mean of 16 years (10.3 to 19.9). The mean age of the surviving patients at the time of operation was 41.3 years (26.0 to 49.0). Of these, eight have undergone revision of their acetabular component for aseptic loosening. None of the femoral components has had revision for aseptic loosening giving a survival rate of 100% at 16 years (95% confidence interval 89% to 100%).

The Furlong hydroxyapatite-ceramic-coated femoral component gives excellent long-term survival in young and active patients.






(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General